Replies to post #9755 on Amarin Corp Plc (AMRN)

[ggwpq]

If FDA decides to wait for the outcome study before approving V for ANCHOR, it will send the wrong message to the medical community. Lovaza would continue to be prescribed off-label, causing more AFIB and increased LDL for at-risk patients. Why would FDA want that to happen? Unless it's totally corrupt and in bed with BP like GSK.

[Whalatane]

WM
First lesson in marketing and launching any business ...is saturation .
I would be furious if a mag/ journal I had paid for full page advertising in never even acknowledged the existence of my product ....weither they liked it or not.
Re PA prescribing
My wife is a PA and writes scrips in her field ..dialysis . She assures me that any PA in Cardiology or related field like diabetes MUST know about the drugs available for treatment ....

Ps to JL ....re " They know nothing "
I personally know ( and have email contact with one ) the co directors of the Adult Lipid Center at UCSF .
With their 30 yrs of experience and hundreds of peer reviewed articles I think they know some thing ...wouldn't you ?
By the way ..Dr Dean Ornish has a daughter in my youngest sons class. My wife talks to him ...next time I see him at pickup I'll have to ask him if he " knows anything " ....with all due respect.

Will , JL ,WM ,Ajax and others ...you are great reads ....but AMRN is one of the smallest position I own...What's the currently the largest YTD ? ..let's just say Elon Musk is the next Steve Jobs out here.
AK